Subject: For Immediate Dissemination - THC BioMed Intl Ltd. - Sale of Two Strata Units
Word Document
File: '\\swfile\EmailIn\20250605 170706 Attachment THC Press Release Sale of Strata Unit Closing June 4 2025 1379-5353-3207 v.1.docx'
1379-5353-3207, v. 1
THC BIOMED INTL LTD.
P.O. Box 20033 Towne Centre
Kelowna, B.C. V1Y 9H2
www.thcbiomed.com
THC BioMed Intl Ltd. Sells Two Strata Units in Kelowna, B.C.
Vancouver, Canada - June 5, 2025 - THC BioMed Intl Ltd. (CSE:THC) ("THC BioMed") or (the "Company") is pleased to announce that it completed the sale of two of its strata units at its Acland Road location in Kelowna, B.C. on June 4, 2025.
The total purchase price for both units was $700,000. $26,250 was paid out in real estate commissions. The Company expects to use the remainder of the proceeds to pay for other expenses of the transaction, the mortgage payout, CRA, other creditors and general working capital.
The buyer is an Arm's-Length Party.
The Issuer has leased these units, which contain a total of 3,697 square feet of rentable space, back from the Buyer to continue its business operations therein. The leases are for a period of 24 months. Rent for each unit is $2,500 per month, with additional rent of $4.97 per square foot of rentable space for payment of the proportionate share of operating costs. Rent in the second 12 months will increase by 7%. After that, the landlord is to set a new rent in his discretion. There is a three-month notice period for termination. All amounts are subject to GST and PST, as applicable. The Issuer is required to take out commercial renter's insurance on the units and pay utilities.
About THC Biomed:
THC Biomed is a leading cannabis company dedicated to producing high-quality, diverse cannabis products. With a focus on innovation and consumer satisfaction, THC Biomed strives to meet the evolving needs of cannabis enthusiasts through continuous research, development, and product excellence.
For more information, contact:
John Miller, CEO
THC BioMed Intl Ltd.
T: 1-844-THCMEDS
E: info@thcbiomed.com
Forward-Looking Information:
This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of THC BioMed. Forward-looking information is based on certain key expectations and assumptions made by the management of THC BioMed. In some cases, you can identify forward-looking statements using words such as "will," "may," "would," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "could" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Although THC BioMed believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because THC BioMed can give no assurance that they will prove to be correct. THC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.
© 2026 Canjex Publishing Ltd. All rights reserved.